BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, March 25, 2026
Home
»
Topics
» Hematologic, BioWorld Science
Hematologic, BioWorld Science
RSS
Novel fibrinogen/integrin receptor antagonists described by Merck KGaA
July 22, 1997
DuPont Merck prepares anticoagulant aminoboronic acids
July 21, 1997
Fibrinogen-antagonistic oxopiperazine derivatives from Yamanouchi
July 17, 1997
Potent, orally active fibrinogen antagonist developed at Merck & Co.
July 17, 1997
Texas Biotechnology initiates NDA filing for Novastan
July 16, 1997
Merck & Co. develops potent and selective pyridinone acetamide thrombin inhibitor
July 16, 1997
Lp(a)-dependent actions of LMWH
July 14, 1997
Antithrombotic efficacy of TAK-029 in animal models
July 11, 1997
Roberts seeks European approval of Agrylin
July 11, 1997
ReoPro effective in baboon models of human renal disorders
July 11, 1997
Previous
1
2
…
412
413
414
415
416
417
418
419
420
…
446
447
Next